Vitamin D Deficiency Clinical Trial
Official title:
A Single Wintertime Dose of Vitamin D3 to Prevent Winter Decline in Vitamin D Concentrations in Healthy Adults: A Pilot Study
The purpose of this study is to determine if a single dose of vitamin D administered orally in the fall will provide adequate vitamin D in healthy individuals for the duration of the winter, during which vitamin D levels are known to decrease. The investigators are also interested in finding out if this level of vitamin D will provide adequate levels for the remainder of the year. While the benefits of once-yearly vitamin D administration are clear for patients with osteoporosis, osteomalacia, rickets, and other conditions associated with vitamin D deficiency and high bone turn-over, studies have not been performed in which high doses of vitamin D were used to prevent the seasonal decline of vitamin D concentrations in healthy individuals. These findings could provide evidence to support vitamin D administration to healthy individuals in the wintertime to improve health outcomes, and provide the basis for additional studies in both healthy and sick populations.
Vitamin D, synthesized from 7-dehydrocholesterol during ultraviolet- B exposure, aids in the
absorption of calcium from the G.I. tract. Indirectly, by maintaining optimal calcium
homeostasis, adequate vitamin D concentrations are essential in skeletal health (by
preventing rickets and osteomalacia), cardiovascular health (by lowering the risk for
hypertension), and ultimately decreasing mortality. Due to decreased direct sunlight
exposures in the winter (characterized by limited outdoor activity, increased clothing
coverage, and angle of the sun), vitamin D concentrations are shown to decline in individuals
over the winter. Once-yearly administration of a bolus of vitamin D offers a means of
preventing the seasonal decline in vitamin D status and preventing vitamin D deficiency. If
proven successful, a once-yearly dose of vitamin D would provide improved compliance relative
to daily or monthly dosing and provide an inexpensive and easy way to ensure optimal
concentrations of vitamin D year-round.
This pilot study plans to investigate if once a year dosing with vitamin D during the winter
months in self-identified healthy adults will be effective in maintaining optimal vitamin D
status for the entire year. In brief, this study will be a randomized, double blind,
placebo-controlled study to evaluate the efficacy of 250,000 IU of vitamin D3 compared to
placebo given once in 30 healthy individuals (15 subjects per arm) in November. The serum
25(OH)D (the best measurable level of vitamin D status) will be measured after both 3-4
months and 1 year to determine the efficacy of the dose relative to the 15 healthy controls.
The intent of this clinical investigation is not to evaluate the dietary supplement's ability
to diagnose, cure, mitigate or prevent disease. This study is to evaluate blood
concentrations of this regimen of vitamin D.
Ultimately, this study hopes to determine if a single dose of vitamin D administered orally
in the fall will provide adequate vitamin D in healthy young individuals for the 3 months
during winter, during which vitamin D levels are known to decrease, and over the entire year.
These findings could provide evidence to support vitamin D administration to healthy
individuals in wintertime to improve health outcomes, and provide the basis for additional
studies in both healthy and sick populations.
Secondary outcomes of this study will evaluate other hypothesized effects of vitamin D on
biomarkers affecting health status and immunity, including markers of inflammation and
markers of iron status.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04244474 -
Effect of Vitamin D Supplementation on Improvement of Pneumonic Children
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05459298 -
ViDES Trial (Vitamin D Extra Supplementation)
|
N/A | |
| Completed |
NCT04476511 -
The Efficacy and the Safety of Vitamin D3 30,000 IU for Loading Dose Schedules
|
Phase 3 | |
| Suspended |
NCT03652987 -
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
|
||
| Completed |
NCT03920150 -
Vitamin D 24'000 IU for Oral Intermittent Supplementation
|
Phase 3 | |
| Completed |
NCT03264625 -
The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis
|
Phase 2 | |
| Completed |
NCT04183257 -
Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
|
Phase 4 | |
| Recruiting |
NCT05084248 -
Vitamin D Deficiency in Adults Following a Major Burn Injury
|
Phase 4 | |
| Completed |
NCT05506696 -
Vitamin D Supplementation Study
|
N/A | |
| Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
| Completed |
NCT03234218 -
Vitamin D Levels in Liver Transplantation Recipients Prospective Observational Study
|
||
| Completed |
NCT03203382 -
Corneal Nerve Structure in Sjogren's
|
||
| Completed |
NCT02714361 -
A Study to Investigate the Effect of Vitamin D3 Supplementation on Iron Status in Iron Deficient Women
|
N/A | |
| Completed |
NCT02906319 -
Vitamin D and HbA1c Levels in Diabetic Patients With CKD
|
N/A | |
| Completed |
NCT02118129 -
Vitamin D Among Young Adults: an Intervention Study Using a Mobile 'App'.
|
N/A | |
| Completed |
NCT02187146 -
The Effects of Serum Vitamin D and IVF Outcome
|
N/A | |
| Completed |
NCT02275650 -
The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter
|
N/A | |
| Not yet recruiting |
NCT01419821 -
Vitamin D and Its Affect on Growth Rates and Bone Mineral Density Until Age 5
|
N/A | |
| Completed |
NCT01741181 -
Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2
|
Phase 4 | |
| Completed |
NCT01688102 -
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
|
N/A |